Search Results - "AIKO NAGAYAMA"

Impact of neoadjuvant and adjuvant chemotherapy on invasive lobular carcinoma: A propensity score‐matched analysis of SEER data.

Authors: Watanuki, Rurina Hayashida, Tetsu Yokoe, Takamichi et al.

Source: Breast Journal. Sep2020, Vol. 26 Issue 9, p1765-1770. 6p.

Author Correction: Meiotic protein SYCP2 confers resistance to DNA-damaging agents through R-loop-mediated DNA repair.

Authors: Wang Y Gao B Zhang L et al.

Source: Nature communications [Nat Commun] 2024 May 07; Vol. 15 (1), pp. 3819. Date of Electronic Publication: 2024 May 07.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE

Clinical predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer.

Authors: AYAKO NAKASHOJI AKIRA MATSUI AIKO NAGAYAMA et al.

Source: Oncology Letters. Oct2017, Vol. 14 Issue 4, p4135-4141. 7p.

Acknowledgment to the Reviewers of International Journal of Molecular Sciences in 2022.

Authors: Office, IJMS Editorial¹ (AUTHOR)

Source: International Journal of Molecular Sciences. Feb2023, Vol. 24 Issue 3, p2105. 248p.

Phase II trial of eribulin mesylate as a first- or second-line treatment for locally advanced or metastatic breast cancer: a multicenter, single-arm trial.

Authors: Hayashida, Tetsu Jinno, Hiromitsu Mori, Katsuaki et al.

Source: BMC Cancer. 6/28/2018, Vol. 18 Issue 1, p1-7. 7p. 4 Charts, 2 Graphs.

Response.

Authors: Aiko Nagayama Tetsu Hayashida Hiromitsu Jinno et al.

Source: JNCI: Journal of the National Cancer Institute. Apr2015, Vol. 107 Issue 4, p1-2. 2p.

A genome-wide CRISPR/Cas9 knockout screen identifies SEMA3F gene for resistance to cyclin-dependent kinase 4 and 6 inhibitors in breast cancer.

Authors: Kawai Y Nagayama A Miyao K et al.

Source: Breast cancer (Tokyo, Japan) [Breast Cancer] 2025 Jan; Vol. 32 (1), pp. 120-131. Date of Electronic Publication: 2024 Oct 01.

Publication Type: Journal Article

Journal Info: Publisher: Maruzen Co Country of Publication: Japan NLM ID: 100888201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-4233 (Electronic) Linking ISSN: 13406868 NLM ISO Abbreviation: Breast Cancer Subsets: MEDLINE

MUC1-C dependency in drug resistant HR+/HER2- breast cancer identifies a new target for antibody-drug conjugate treatment.

Authors: Nakashoji A Bhattacharya A Ozawa H et al.

Source: NPJ breast cancer [NPJ Breast Cancer] 2025 Apr 26; Vol. 11 (1), pp. 39. Date of Electronic Publication: 2025 Apr 26.

Publication Type: Journal Article

Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Efficacy and safety of HER2 inhibitors in combination with or without pertuzumab for HER2-positive breast cancer: a systematic review and meta-analysis.

Authors: Chen, Shanshan Liang, Yu Feng, Zhangying et al.

Source: BMC Cancer. 10/21/2019, Vol. 19 Issue 1, pN.PAG-N.PAG. 1p. 1 Diagram, 3 Charts, 4 Graphs.

Takashi Shimura : Chameleon of Japanese Cinema

Authors: Scott Allen Nollen

Resource Type: eBook.

Subjects: Motion pictures--Japan--History--20th century, Motion picture actors and actresses--Japan--Biography

Categories: PERFORMING ARTS / Film / History & Criticism

The Keio HBOC Center: A Model of Hereditary Breast and Ovarian Cancer Management.

Authors: Kobayashi Y Masuda K Seki T et al.

Source: The Keio journal of medicine [Keio J Med] 2025 Sep 25; Vol. 74 (3), pp. 124-129. Date of Electronic Publication: 2025 Jun 20.

Publication Type: Journal Article

Journal Info: Publisher: Keio Gijuku Daigaku Igakubu Country of Publication: Japan NLM ID: 0376354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-1293 (Electronic) Linking ISSN: 00229717 NLM ISO Abbreviation: Keio J Med Subsets: MEDLINE

Current Situation and Future Directions of Risk-reducing Salpingo-oophorectomy.

Authors: Masuda K Kobayashi Y Seki T et al.

Source: The Keio journal of medicine [Keio J Med] 2025 Sep 25; Vol. 74 (3), pp. 138-145. Date of Electronic Publication: 2025 Mar 22.

Publication Type: Journal Article; Review

Journal Info: Publisher: Keio Gijuku Daigaku Igakubu Country of Publication: Japan NLM ID: 0376354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-1293 (Electronic) Linking ISSN: 00229717 NLM ISO Abbreviation: Keio J Med Subsets: MEDLINE

Exploring Breast Cancer Risk Management in HBOC Patients: Image Surveillance Versus Risk-reducing Surgery.

Authors: Seki T Kobayashi Y Masuda K et al.

Source: The Keio journal of medicine [Keio J Med] 2025 Sep 25; Vol. 74 (3), pp. 130-137. Date of Electronic Publication: 2025 Apr 02.

Publication Type: Journal Article; Review

Journal Info: Publisher: Keio Gijuku Daigaku Igakubu Country of Publication: Japan NLM ID: 0376354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-1293 (Electronic) Linking ISSN: 00229717 NLM ISO Abbreviation: Keio J Med Subsets: MEDLINE

Questionnaire survey of healthcare professionals on taxane-induced nail change in Japan.

Authors: Yamamoto K Tanabe Y Nonogaki K et al.

Source: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 Sep 10; Vol. 32 (10), pp. 647. Date of Electronic Publication: 2024 Sep 10.

Publication Type: Journal Article

Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE

Proton Pump Inhibitors and Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Breast Cancer.

Authors: Takahashi K Uozumi R Mukohara T et al.

Source: The oncologist [Oncologist] 2024 Jun 03; Vol. 29 (6), pp. e741-e749.

Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Meiotic protein SYCP2 confers resistance to DNA-damaging agents through R-loop-mediated DNA repair.

Authors: Wang Y Gao B Zhang L et al.

Source: Nature communications [Nat Commun] 2024 Feb 21; Vol. 15 (1), pp. 1568. Date of Electronic Publication: 2024 Feb 21.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Establishment of a deep-learning system to diagnose BI-RADS4a or higher using breast ultrasound for clinical application.

Authors: Hayashida T Odani E Kikuchi M et al.

Source: Cancer science [Cancer Sci] 2022 Oct; Vol. 113 (10), pp. 3528-3534. Date of Electronic Publication: 2022 Aug 03.

Publication Type: Journal Article

Journal Info: Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE

Feasibility study on collecting patient-reported outcomes from breast cancer patients using the LINE-ePRO system.

Authors: Hayashida T Nagayama A Seki T et al.

Source: Cancer science [Cancer Sci] 2022 May; Vol. 113 (5), pp. 1722-1730. Date of Electronic Publication: 2022 Mar 26.

Publication Type: Journal Article

Journal Info: Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE

Acknowledgement to Referees.

Source: Targeted oncology Nov2021; Vol. 16 (6).

Journal Info: Publisher: Springer Nature ISSN: 1776-2596

Novel Therapies for Metastatic Triple-Negative Breast Cancer: Spotlight on Immunotherapy and Antibody-Drug Conjugates.

Authors: Nagayama A Vidula N Bardia A

Source: Oncology (Williston Park, N.Y.) [Oncology (Williston Park)] 2021 May 13; Vol. 35 (5), pp. 249-254. Date of Electronic Publication: 2021 May 13.

Publication Type: Journal Article; Review

Journal Info: Publisher: MultiMedia Healthcare Country of Publication: United States NLM ID: 8712059 Publication Model: Electronic Cited Medium: Internet ISSN: 0890-9091 (Print) Linking ISSN: 08909091 NLM ISO Abbreviation: Oncology (Williston Park) Subsets: MEDLINE